pacDNA

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://pacdna.com/

Last Round

Grant

Jan 17, 2025

Total Funding Raised

$2.99M

Company Overview

pacDNA is a biotechnology company that develops oligonucleotide therapeutics for the treatment of cancer and rare genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

oligonucleotide therapeuticsdrug delivery platformextra-hepatic deliverynucleic acid deliveryRNA medicinebottlebrush polymeroligonucleotide conjugatepharmaceutical partnershipssiRNA deliveryASO deliverypreclinical biotechnologyout-licensingrare genetic disorderscancer therapeuticsMyotonic dystrophy type 1STTRSBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

pacDNA Comps

Public and private peers based on sector, stage, and business model.

pacDNA comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

pacDNA Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jan 17, 2025
Grant	Sep 1, 2023
Grant	Dec 1, 2022
Accelerator	Sep 1, 2022
Grant	Jul 1, 2022

View all Funding Rounds

pacDNA Investors

Notable investors and investment history

pacDNA investors
Investor	Rounds
NIH RADx	Grant
Congressionally Directed Medical Research Programs	Grant
Northeastern University Center for Research Innovation	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 17, 2025
$490K grant from Congressionally Directed Medical Research Programs
Sep 1, 2023
$50K grant received from Northeastern University Center for Research Innovation.

View all signals

pacDNA Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

pacDNA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about pacDNA's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Year Founded2023

Last FundingJan 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.